Navigation Links
BioSpecifics Technologies Corp. Announces Sale of Stock in Private Placement Offering

LYNBROOK, N.Y., Jan. 14 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Pink Sheets: BSTC.PK) today announced that it sold 200,000 unregistered shares of its common stock, in a private placement offering to an investment fund, at a purchase price of $10.50 per share for aggregate proceeds to the Company of $2,100,000.

About BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed and licensed injectable collagenase for three clinical indications. We have a development and licensing agreement with Auxilium Pharmaceuticals for clinical indications in Dupuytren's disease, Peyronie's disease and frozen shoulder (adhesive capsulitis). The indication for Dupuytren's disease is in Phase III trials.

BioSpecifics web site is:

SOURCE BioSpecifics Technologies Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. BioSpecifics to Present at the 9th Annual Healthcare Conference of Acumen Bio Fin Rodman Renshaw LLC
2. HealthCare Technologies Ltd. (NASDAQ: HCTL) Announces Receipt of NASDAQ Delisting Notice
3. China Medical Technologies Completes Acquisition of BBE
4. EaglePicher Technologies Receives Battery Power Products and Technologys First Annual Innova Award
5. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
6. GSA Selects Cascades Technologies, Inc. (CTi) to Support
7. MultiCell Technologies To Increase Focus on Therapeutic Candidates
8. Senesco Technologies Closes on Additional $4.0 Million of Previously Announced Financing
9. Neurobiological Technologies, Inc. Reports Retirement of Ronald E. Cape, Ph.D., from Board
10. ISTO Technologies to Present at OneMedPlace Finance Forum
11. Siemens Building Technologies Helping Companies Participate in EPA Labs21 Movement With Comprehensive Compliance Solution Strategy
Post Your Comments:
(Date:10/13/2015)... Calif. , Oct. 13, 2015  Cepheid (Nasdaq: ... quarter ending September 30, 2015. --> ... results, total revenue for the third quarter of 2015 ... loss per share is expected to be approximately $(0.32) ... results, non-GAAP net loss per share for the third ...
(Date:10/13/2015)... Research and Markets( ) has announced ... for Bone Morphogenetic Protein Growth Factor Therapy - 16 ... --> --> Bone morphogenetic proteins ... bone after a fracture. In nature, these proteins have ... of the skeleton. There are twenty different BMPs that ...
(Date:10/13/2015)... ... October 13, 2015 , ... AxioMx Inc. ... it has received a Phase I Small Business Innovative Research (SBIR) grant (1R43GM112204-01A1). ... General Medical Sciences (NIGMS), will fund the development of a technique to rapidly ...
(Date:10/13/2015)... 13, 2015  According to Kalorama Information, the ... $102 billion by the end of 2015. Clinical ... industry, as it is estimated that approximately 80% ... tests. In addition to diagnosing patients, clinical lab ... progression, monitor drug treatment and conditions, and determine ...
Breaking Biology Technology:
(Date:9/28/2015)... , Sept. 28, 2015 CLEAR, ... that its expedited traveler service is coming ... transforms travel, bringing a frictionless experience, serious ... "CLEAR offers our travelers an ... service," said Jim Smith , Executive ...
(Date:9/28/2015)... 28, 2015 The global ... USD 12.03 billion by 2020, growing at a CAGR ... as Backside Illumination (BSI) technique to improve picture quality ... period.      (Logo: , ... to reduce loss and, thus, reduce the noise interference ...
(Date:9/28/2015)... SAN JOSE, Calif. , Sept. 28, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that Lenovo ... area touch fingerprint sensor, FS4202, for its latest smartphone, ... enables secure, password-free access to unlock the device and ... consumers. The feature-rich Natural ID FS4202 ...
Breaking Biology News(10 mins):